Energy alterations in patients with pulmonary thrombosis after COVID-19 treatment

Energy alterations in patients with pulmonary thrombosis after COVID-19 treatment

9^th International Conference on COPD and Lung Health
September 13, 2022 | Webinar

Huang Wei Ling

Medical Acupuncture and Pain Management Clinic, Brazil

Abstract:

Introduction: There are some studies in the literature reporting cases of pulmonary thromboembolism after treatment of acute phase of SARS-CoV-2 infection. Purpose: The purpose of this study is to show that patients that have pulmonary thromboembolism has in the back ground prior to COVID-19, energy deficiency in the five internal massive organs, responsible for the production of energy necessary to keep the Blood flowing normally inside the blood vessels. The treatment used nowadays to treat patient with SARS CoV-2 infection can reduce even more this energy and can cause Blood stagnation inside the blood vessels in any part of the body, in this case, in the pulmonary vessels. Methods: Through one case report of 38 years-old female patient with history of SARS-CoV-2 infection in on February 2nd 2021. In the beginning of her symptoms, she presented only runny nose and flu-like symptoms. She evolves to body pain and headache and in the third day, she tested positive to SARS-CoV-2. It was prescribed Ivermectin and Azithromycin and she stayed 14 days isolated at home. On 16th day since the first manifestation, she returned to work and began to feel left chest pain. She did many exams to see if the Heart was compromised but nothing was found. There was only alteration in the pulmonary artery pressure and after it was diagnosed pulmonary thrombosis after performing angio tomography. She started to use Rivaroxaban and after this treatment, she improved and the symptoms disappeared but she is still using the medication until today. She went to my clinic in January 2022 to treat anxiety and she told me about all history of SARS-C0V-2 infection and complications. I performed to measurement of her internal massive organs through a crystal-pendulum. Results: What I found was a complete lack of energy inside the five internal massive organs (Liver, Heart, Spleen, Lungs, and Kidney) responsible for the production of Yin, Yang, Qi and Blood to keep the blood flowing inside the blood vessels. Conclusion: The conclusion of this study is that patients with pulmonary thromboembolism post COVID-19 symptoms can have energy deficiency inside the five internal massive organs and the use of highly concentrated medications to treat this condition and many other clinical conditions can worse more this reduction in energy (according to Arndt Schultz Law) and cause stagnation of Blood inside the blood vessels and evolve in this case to pulmonary thromboembolism.

Biography:

Huang Wei Ling, born in Taiwan, raised and graduated in medicine in Brazil, specialist in infectious and parasitic diseases, a general practitioner and parenteral and enteral medical nutrition therapist. Once in charge of the hospital infection control service of the city of Franca’s General Hospital, she was responsible for the control of all prescribed antimicrobial medication and received an award for the best paper presented at the Brazilian Hospital Infection Control Congress in 1998. Since 1997, she works with the approach and treatment of all chronic diseases in a holistic way, with treatment guided through the teachings of traditional Chinese medicine and Hippocrates. Researcher in the University of Sao Paulo, in the ophthalmology department from 2012 to 2013.

PDF HTML